company

HBC THERAPEUTICS AS

6003 Ã…LESUND

Return on Equity
99,63 %
Current Ratio
0,04
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue0
Net Income−266 000
Total Assets12 000
Total Equity−267 000
Income (NOK)2022
Revenue0
Expenditure266 000
Operating Profit−266 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−266 000
Tax0
Net Income−266 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets12 000
Total Assets12 000
Total Retained Equity−5 462 000
Total Equity−267 000
Total Long-Term Debt0
Total Current Debt279 000
Total Equity and Debt12 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold19 000
Salary Costs0
Depreciation188 000
Impairment0
Expenditure266 000
Operating Profit−266 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−266 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank9 000
Total Current Assets12 000
Total Assets12 000
Total Equity−267 000
Short-Term Group Debt233 000
Total Long-Term Debt0
Creditors45 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt279 000
Total Equity and Debt12 000
Financial indicators2022
Return on Equity99,63 %
Debt-to-Equity Ratio−0
Operating Profit Margin-
Current Ratio0,04
Quick Ratio0,04
Equity Ratio−22,25
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English